Determining Complement Binding Donor Specific HLA Antibody by Luminex Assay - Is It Clinically Relevant?

被引：0
|
作者：
Lunz, J. [1 ]
Webber, S. [1 ]
Soltys, K. [1 ]
Shapiro, R. [1 ]
Teuteberg, J. [1 ]
Feingold, B. [1 ]
Morrell, M. [1 ]
Jelinek, L. [1 ]
Zeevi, A. [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1520
引用
收藏
页码：472 / 472
页数：1
相关论文
共 50 条
  • [31] DONOR-SPECIFIC CLASS II HLA-DQ COMPLEMENT BINDING ANTIBODY IS ASSOCIATED WITH SEVERE REJECTION IN LUNG TRANSPLANTATION.
    Zeevi, Adriana
    Marrari, Marilyn
    Lunz, John
    Morrell, Matthew
    Gries, Cynthia
    McDyer, John
    Pilewski, Joseph
    Ensor, Christopher
    Duquesnoy, Rene
    Bermudez, Christian
    HUMAN IMMUNOLOGY, 2013, 74 : 100 - 100
  • [32] THE COMPLEMENT-BINDING CAPABILITY OF PRE-TRANSPLANT DONOR-SPECIFIC HLA-ANTIBODY IS NOT PREDICTIVE FOR KIDNEY TRANSPLANTATION OUTCOMES
    Hoenger, Gideon
    Amico, Patrizia
    TISSUE ANTIGENS, 2015, 85 (05): : 412 - 413
  • [33] TRANSPLANTATION DONOR-RECIPIENT CROSSMATCH ASSAY BY TWO METHODS (CDC AND LUMINEX) AND ASSOCIATION WITH LUMINEX ANTIBODY DETERMINATION
    Fylaktou, Asimina
    Miserlis, Grigorios
    Chouridi, Maria
    Makrobasili, Fani
    Chatzika, Georgia
    Zaras, Charalampos
    TISSUE ANTIGENS, 2014, 84 (01): : 90 - 90
  • [34] Invitrogen's dynachip automated HLA antibody analysis (DynaChip) assay: does it define clinically relevant antibodies
    Phelan, D.
    Pang, S.
    Jendrisak, M.
    Mohanakumar, T.
    TISSUE ANTIGENS, 2007, 69 (05): : 503 - 503
  • [35] CLINICAL RELEVANCE OF PREFORMED HLA DONOR SPECIFIC ANTIBODIES DETECTED BY SINGLE ANTIGEN LUMINEX ASSAY ON KIDNEY TRANSPLANTS PERFORMED WITH NEGATIVE COMPLEMENT DEPENDENT CYTOTOXICITY T AND B CROSSMATCHES
    Holanda-Cavalcanti, Alexandre
    Campos, Erika F.
    Grenzi, Patricia C.
    De Marco, Renato
    Rampim, Gisele F.
    Tedesco-Silva, Helio
    Medina-Pestana, Jose O.
    Gerbase-DeLima, Maria
    HUMAN IMMUNOLOGY, 2012, 73 : 63 - 63
  • [36] Development and Validation of a Microsphere-Based Luminex Assay for Rapid Identification of Clinically Relevant Aspergilli
    Etienne, Kizee A.
    Kano, Rui
    Balajee, S. Arunmozhi
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (04) : 1096 - 1100
  • [37] Are all donor-specific antibodies detected by solid phase assay before transplantation clinically relevant?
    Aubert, V
    Venetz, J-P
    Pantaleo, G.
    Pascual, M.
    SWISS MEDICAL WEEKLY, 2009, 139 (9-10) : 23S - 23S
  • [38] Are complement-fixing antibodies against denatured HLA antigens clinically relevant?
    Visentin, Jonathan
    Guidicelli, Gwendaline
    Taupin, Jean-Luc
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2016, 100 (03) : 532 - 533
  • [39] Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation
    Salvade, Igor
    Aubert, Vincent
    Venetz, Jean-Pierre
    Golshayan, Dela
    Saouli, Anne-Catherine
    Matter, Maurice
    Rotman, Samuel
    Pantaleo, Giuseppe
    Pascual, Manuel
    HUMAN IMMUNOLOGY, 2016, 77 (06) : 483 - 489
  • [40] CORRELATION OF FLOW HLA ANTIBODY SCREENING AND LUMINEX SINGLE ANTIGEN BEAD ASSAY.
    Lopes, Karine E.
    Clark, Adella
    Wan, Liang
    Wegner, Wendy E.
    Chen, Dong-Feng
    HUMAN IMMUNOLOGY, 2014, 75 : 76 - 76
12345